| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.2 | 0.007 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.008 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |